Table 3 differences between ECMO and ventilated patients.
| Â | ECMO patients | Non-ECMO patients |
|---|---|---|
Number (%) | 7 | 5 |
Male sex, N (%) | 6 (85 .7%) | 2 (40%) |
Age (years) | 45 (37-46.5) | 42 (39-51) |
BMI | 27 (23.5-36.5) | 27 (25-29) |
SAPS II | 44 (39-50.5) | 28 (27-28) |
Patients with comorbidities, N (%) | 5 (71 .4%) | 2 (40%) |
Patients with proved coinfection, N (%) | 2 (28 .6%) | 0 |
Days from onset to ICU admission | 6 (6-7.5) | 7 (7-9) |
§ PaO 2 (mmHg)/FiO 2 | 48.7 (46.8-58) | 116 (107-141) |
§ PaCO 2 (mmHg) | 81.6 (60.6-88) | 57 (55.8-63) |
§ pH | 7.25 (7.20-7.30) | 7.33 (7.28-7.34) |
§ Respiratory rate (N/min) | 10 (8.5-15) | 20 (18-22) |
§ PEEP (cmH 2 O) | 14 (11-15) | 14 (11-15) |
§ Static compliance(ml/cmH 2 O) | 34 (30-38) | 32 (23-38) |
§ White cells count (N*1000/ml) | 11 (9.1-13.3) | 7.03 (6.7-8.6) |
§ Platelets count (N*1000/ml) | 151 (115.5-218.5) | 158.5 (125.3-182.5) |
§ Lactate dehydrogenase (U/l) | 445 (372.5-920.5) | 627 (607-632) |
§ Creatine kinase (U/l) | 477 (189-890.3) | 435 (281.5-695) |
§ Aspartate aminotransferase (U/l) | 54 (42-121.5) | 53 (42-78) |
§ Alanine aminotransferase (U/l) | 38 (25.5-41) | 37 (29-45) |
§ C-reactive protein (mg/dl) | 83.5 (77.5-315.7) | 127.5 (96.3-158.8) |
§ Serum creatinine (mg/dl) | 1.02 (0.79-1.72) | 0.81 (0.55-0.85) |
§ Procalcitonin (ng/ml) | 4.3 (2.7-29.4) | 1.9 (0.2-2.6) |
CVVH, N (%) | 2 (28 .6%) | 0 |
Chest radiographs (mean per patient) | 9.6 | 4.2 |
Chest CT-scan (mean per patient) | 1.6 | 0.8 |
Duration of mechanical ventilation (days) | 19 (12-36) | 9 (5-11) |
ICU lenght of stay (days) | 23 (17.5-38) | 11 (8-14) |
Packed Red Blood Cells Units, N | 4 (1-6) | 1 (0-3) |
Mortality, N (%) | 1 (14.3%) | 0 (0%) |